In breast cancer patients the role of hypoxia as a predictor for survival has been demonstrated through immunohistochemical detection of hypoxia-dependent markers, such as hypoxia-inducible factor-1α (HIF-1α) and carbonic anhydrase IX (CAIX) [2,3]. This evidence concerns the gene CA9 and breast carcinoma.